Dave has a chemistry background with over 25 years of drug discovery and development expertise in pharma at Roche/Syntex and at early stage biotech companies Cytokinetics and Iconix. Dave has been responsible for the non-clinical aspects of pharmaceutical R&D from early drug discovery and optimization through pre-clinical development and manufacturing in support of clinical studies. He has led scientific and technical teams to produce 7 novel drug candidates that advanced to clinical trials in oncology and inflammatory, cardiovascular and neuromuscular disease.